Europe’s Cannabis-Friendly Hotspots Could Trigger an Economic Shift
by Bethan Rose
The legal cannabis market has been on the rise for quite some time. Statistics published in Stellar Market Research’s new report indicate that the industry is set to continue skyrocketing. The market was valued at USD $28.26 billion in 2021, and total revenue is predicted to surge at a compound annual growth rate (CAGR) of 32.04% between 2022 and 2027.
According to industry analysts, the cannabis market will soar to a valuation of $149.8 billion by the year 2027. The new report examines market growth drivers and segments. Several notable participants provided data for the report, highlighting a handful of dominant regions, including APAC, Europe, MEA, North America, and South America.
Key data analysis featured in the report extends over a three-year historical period from 2017-2020. In addition to the unique cannabis markets, challenges, growth drivers, limitations, and opportunities featured in Stellar Market Research’s detailed analysis, the report also features investor recommendations.
Researchers from Stellar Market Research have outlined several key factors stimulating industry success, including increasing disposable incomes. According to the report, the increasingly aging population and illness amplify the demand for medicinal cannabis. Older adults face a higher risk of developing chronic diseases, such as arthritis, cancer, epilepsy, and migraines. As a result, more physician visits are necessary.
The researchers also spotlighted rising demand in the agriculture sector for legal cannabis. Pesticides can be created using recreational cannabis, thus offering agricultural workers the opportunity to utilize a less harmful option than conventional pesticides.
Furthermore, the report emphasizes that cannabis offers a safer alternative to traditional treatment options and produces fewer adverse side effects. Additionally, cannabis-based medicines allow patients to minimize their opioid dosage and frequency while still benefiting from pain relief.
As a plant that is shrouded in misconception, many governments are outlawing the use of cannabis. Even though cannabis is permitted in specific regions of Africa, Europe, North America, and South America, it is still forbidden by law in the majority of Middle Eastern and Asian countries, including Japan, India, and Korea. Due to these strict regulations, consumption, possession, purchase, and sale are deemed criminal acts. Consequently, cannabis market growth is somewhat restricted.
The potentially adverse side effects of specific cannabis strains—particularly those rich in the psychoactive compound delta-9 tetrahydrocannabinol (THC)—hinder market growth. The Stellar Market Research team also noted the addictive nature of cannabis as one of the restraints to the cannabis market. While cannabis is believed to be non-addictive, dependence on the plant has been explicitly documented.
Cannabis legalization is unfolding across the Asia Pacific region—something that has been largely stimulated by the rise of legal cannabis across most nations in Europe, North America, and South America. China, which already boasts a significant market for industrial hemp, is expected to emerge as a serious contender for industrial cannabis in the foreseeable future.
A focal point of the report was that many key players in the cannabis businesses are patiently waiting for legislative advancement in the Asia Pacific area. If and when this happens, numerous countries across the region stand to reap the rewards of large-capacity, low-cost production. Researchers believe that this will open up immense opportunities for legal cannabis.
To achieve a clearer understanding of growth drivers in the legal cannabis industry, researchers segmented the market as follows:
Some of the key takeaways of this report were as follows:
Click here to read the full cannabis market report from Stellar Market Research.
According to research, “Migraine is highly prevalent, affecting 12% of the population, attacking up to 17% of women and 6% of men yearly. Among children, it tends to happen more in girls than boys.” A migraine can be very disabling and last from hours to two or three days. Migraines are considered to be the…
PTSD can have far-reaching effects on health, functionality as well as on quality of living, which is why having access to effective treatment is so important. If you are living with PTSD or are living with someone who has PTSD, you would have first-hand experience with how challenging it can be getting through life on…
Up until recently, lack of cannabis education meant that people were blissfully unaware of the fact that the plant is not limited to just one strain and, therefore, does not produce just one type of effect. Fortunately, agricultural experimentation has led to the market exploding in terms of strains that can satisfy everyone, from beginners…
Using cannabis to help combat anxiety is a tricky business. Studies have given us significant evidence that cannabis can be used to help cope with anxiety and because anxiety is so common, that’s an extremely welcome piece of information. In fact, 72% of daily cannabis users reported consumption to relax or relieve tension and 58%…
A cannabis compound that has been described as “cutting-edge” and “so elusive, laboratories often misidentify the compound as CBC (cannabichromene) or CBL (cannabicyclol)” is finally becoming better understood. Delta-10-tetrahydrocannabinol (delta-10 THC) is a need-to-know cannabinoid, and here’s why. What Is Delta-10 THC? Does Delta-10 Get You High? Is Delta-10 Safe? How Is Delta-10 Created? Is…
The U.S. Secret Service (USSS) recently loosened its applicant drug use policy to be more accommodating to past cannabis consumers. Candidates of all…
Nebraska advocates are working to get medical cannabis on the ballot, THC seltzers are building buzz in Tennessee, and researchers tested CBD…
The anti-nausea and vomiting effects of cannabis have been known for several centuries. The evidence eventually became so compelling in clinical trials…